Loading...
•
Dec 31, 2019
Astrana Health Q4 2019 Earnings Report
Apollo Medical Holdings, Inc. reported improved financial performance in Q4 2019, marked by revenue growth and increased net income.
Key Takeaways
ApolloMed reported a strong Q4 2019 with a 68% increase in total revenue to $178.8 million and a net income of $6.7 million, driven by recent acquisitions and preferred dividends. The company manages over one million lives and is focused on scalable and profitable growth.
Total revenue increased by 68% to $178.8 million.
Capitation revenue increased by 92% to $148.6 million, representing 83% of total revenue.
Net income attributable to Apollo Medical Holdings, Inc. was $6.7 million, compared to a net loss of $3.1 million in the same quarter of the previous year.
The company entered into a new management services agreement effective January 1, 2020, covering approximately 145,000 members in Southern California.
Revenue by Segment
Forward Guidance
For the year ending December 31, 2020, ApolloMed expects total revenue between $665.0 million and $675.0 million, net income between $20.0 million and $30.0 million, EBITDA between $55.0 million and $67.0 million, and Adjusted EBITDA between $75.0 million and $90.0 million.
Positive Outlook
- Total revenue between $665.0 million and $675.0 million.
- Net income between $20.0 million and $30.0 million.
- EBITDA between $55.0 million and $67.0 million.
- Adjusted EBITDA between $75.0 million and $90.0 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...